Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of a Long-acting Injectable S-892216 in Healthy Adult Participants

NCT07093580 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT07093580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07093580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of a Long-acting Injectable S-892216 in Healthy Adult Participants
Lead sponsor
Shionogi
Phase
Phase 1
Overall status
Recruiting
Start date
July 29, 2025
Completion date
June 30, 2028
Enrollment
98 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants